공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 유전자 패널 시장

Gene Panel

리서치사 Global Industry Analysts, Inc.
발행일 2021년 04월 상품 코드 997462
페이지 정보 영문 179 Pages
가격
US $ 4,950 ₩ 5,625,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 14,850 ₩ 16,875,000 PDF (Global License to Company and its Fully-owned Subsidiaries) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 유전자 패널 시장 Gene Panel
발행일 : 2021년 04월 페이지 정보 : 영문 179 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 유전자 패널 시장 규모는 분석기간(2020-2027년)에 19%의 연평균 복합 성장률(CAGR)로 성장할 전망이며, 2020년 14억 달러에서 2027년에는 48억 달러에 달할 것으로 예측됩니다.

본 보고서에서 분석한 부문 중 하나인 검사 키트는 분석기간 중 19.5%의 CAGR을 나타내고, 33억 달러에 달할 전망입니다.

세계의 유전자 패널(Gene Panel) 시장에 대해 조사했으며, 시장 점유율, COVID-19의 영향, 동향 및 성장요인, 지역별 시장 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

조사 대상 기업 예

  • Agilent Technologies, Inc.
  • ArcherDX, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • GATC Biotech AG
  • GENEWIZ
  • Illumina, Inc.
  • Integrated DNA Technologies (IDT), Inc.
  • Personalis, Inc.
  • QIAGEN GmbH
  • Thermo Fisher Scientific, Inc.

목차

I. 조사 방법

II. 개요

  • 시장 개요
    • 인플루언서 시장 인사이트
    • 세계 시장 궤적
    • 유전자 패널 : 서문
    • 코로나19(COVID-19)의 영향과 다가오는 세계 경기침체
  • 주요 기업
  • 동향 및 성장요인
    • 유전자 패널 방법
    • 유전자 패널 분석과 엑솜 분석
    • 유전자 패널 평가
    • 암 유전자 패널
    • 멀티 유전자 패널 검사
  • 세계 시장 전망

III. 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

IV. 경쟁

  • 기업 개요 : 47개사
LSH 21.04.08

Abstract:

Global Gene Panel Market to Reach $4.8 Billion by 2027

Amid the COVID-19 crisis, the global market for Gene Panel estimated at US$1.4 Billion in the year 2020, is projected to reach a revised size of US$4.8 Billion by 2027, growing at aCAGR of 19% over the period 2020-2027. Test Kits, one of the segments analyzed in the report, is projected to record 19.5% CAGR and reach US$3.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Testing Services segment is readjusted to a revised 17.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $422.4 Million, While China is Forecast to Grow at 18.2% CAGR

The Gene Panel market in the U.S. is estimated at US$422.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$825.2 Million by the year 2027 trailing a CAGR of 18.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17% and 16.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.9% CAGR.

Select Competitors (Total 47 Featured) -

  • Agilent Technologies, Inc.
  • ArcherDX, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • GATC Biotech AG
  • GENEWIZ
  • Illumina, Inc.
  • Integrated DNA Technologies (IDT), Inc.
  • Personalis, Inc.
  • QIAGEN GmbH
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Gene Panel: A Prelude
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Gene Panel Methods
    • Gene Panel Analysis and the Exome Analysis
    • Evaluation of Gene Panel
    • Cancer Gene Panels
    • Multi-Gene Panel Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Gene Panel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World 7-Year Perspective for Gene Panel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
    • TABLE 3: World Current & Future Analysis for Test Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 4: World 7-Year Perspective for Test Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 5: World Current & Future Analysis for Testing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 6: World 7-Year Perspective for Testing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Cancer Risk Assessment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World 7-Year Perspective for Cancer Risk Assessment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 9: World Current & Future Analysis for Diagnosis of Congenital Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 10: World 7-Year Perspective for Diagnosis of Congenital Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 11: World Current & Future Analysis for Pharmacogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 12: World 7-Year Perspective for Pharmacogenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 15: World Current & Future Analysis for Research & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 16: World 7-Year Perspective for Research & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 17: World Current & Future Analysis for Hospital & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 18: World 7-Year Perspective for Hospital & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World 7-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • Active Players in United States
    • TABLE 21: USA Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 22: USA 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
    • TABLE 23: USA Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 24: USA 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
    • TABLE 25: USA Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
  • CANADA
    • Active Players in Canada
    • TABLE 27: Canada Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 28: Canada 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
    • TABLE 29: Canada Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 30: Canada 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
    • TABLE 31: Canada Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
  • JAPAN
    • Active Players in Japan
    • TABLE 33: Japan Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 34: Japan 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
    • TABLE 35: Japan Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 36: Japan 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
    • TABLE 37: Japan Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
  • CHINA
    • Active Players in China
    • TABLE 39: China Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 40: China 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
    • TABLE 41: China Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 42: China 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
    • TABLE 43: China Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
  • EUROPE
    • TABLE 45: Europe Current & Future Analysis for Gene Panel by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 46: Europe 7-Year Perspective for Gene Panel by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
    • TABLE 47: Europe Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 48: Europe 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
    • TABLE 49: Europe Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
    • TABLE 51: Europe Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 52: Europe 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
  • FRANCE
    • Active Players in France
    • TABLE 53: France Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 54: France 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
    • TABLE 55: France Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: France 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
    • TABLE 57: France Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 58: France 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
  • GERMANY
    • Active Players in Germany
    • TABLE 59: Germany Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 60: Germany 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
    • TABLE 61: Germany Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Germany 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
    • TABLE 63: Germany Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 64: Germany 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
  • ITALY
    • Active Players in Italy
    • TABLE 65: Italy Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 66: Italy 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
    • TABLE 67: Italy Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Italy 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
    • TABLE 69: Italy Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 70: Italy 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
  • UNITED KINGDOM
    • Active Players in United Kingdom
    • TABLE 71: UK Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 72: UK 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
    • TABLE 73: UK Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: UK 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
    • TABLE 75: UK Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 76: UK 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
  • REST OF EUROPE
    • Active Players in Rest of Europe
    • TABLE 77: Rest of Europe Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 78: Rest of Europe 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
    • TABLE 79: Rest of Europe Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Rest of Europe 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
    • TABLE 81: Rest of Europe Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 82: Rest of Europe 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
  • ASIA-PACIFIC
    • Active Players in Asia-Pacific
    • TABLE 83: Asia-Pacific Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 84: Asia-Pacific 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
    • TABLE 85: Asia-Pacific Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Asia-Pacific 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
    • TABLE 87: Asia-Pacific Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 88: Asia-Pacific 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027
  • REST OF WORLD
    • Active Players in Rest of World
    • TABLE 89: Rest of World Current & Future Analysis for Gene Panel by Product & Service - Test Kits and Testing Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 90: Rest of World 7-Year Perspective for Gene Panel by Product & Service - Percentage Breakdown of Value Sales for Test Kits and Testing Services for the Years 2020 & 2027
    • TABLE 91: Rest of World Current & Future Analysis for Gene Panel by Application - Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Rest of World 7-Year Perspective for Gene Panel by Application - Percentage Breakdown of Value Sales for Cancer Risk Assessment, Diagnosis of Congenital Diseases, Pharmacogenetics and Other Applications for the Years 2020 & 2027
    • TABLE 93: Rest of World Current & Future Analysis for Gene Panel by End-Use - Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 94: Rest of World 7-Year Perspective for Gene Panel by End-Use - Percentage Breakdown of Value Sales for Research & Academic Institutes, Hospital & Diagnostic Laboratories and Pharmaceutical & Biotechnology Companies for the Years 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 47
Back to Top
전화 문의
F A Q